1. Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic Profile
   Sabine Schleicher et al, 2020, Cells CrossRef
2. Encouraging Early Outcomes of Treatment With Arsenic Trioxide Combined With Chemotherapy for Alveolar Rhabdomyosarcoma in Children: 4 Case Reports
   Xiaomin Peng et al, 2021, Frontiers in Oncology CrossRef
3. Arsenic trioxide potentiates the effectiveness of etoposide in Ewing sarcomas
   Karen A. Boehme et al, 2016, International Journal of Oncology CrossRef
4. Design of Hedgehog pathway inhibitors for cancer treatment
   Jitender Bariwal et al, 2019, Medicinal Research Reviews CrossRef
5. Improved Outcomes with Induction Chemotherapy Combined with Arsenic Trioxide in Stage 4 Neuroblastoma: A Case Series
   Yang Li et al, 2021, Technology in Cancer Research & Treatment CrossRef
6. Arsenic Trioxide Triggers Apoptosis of Metastatic Oral Squamous Cells Carcinoma with Concomitant Downregulation of GLI1 in Hedgehog Signaling
   Raphael Luís Rocha Nogueira et al, 2022, Biomedicines CrossRef
7. Arsenic Trioxide exerts cytotoxic and radiosensitizing effects in pediatric Medulloblastoma cell lines of SHH Subgroup
   Paulo Henrique dos Santos Klinger et al, 2020, Scientific Reports CrossRef
8. Excellent Early Outcomes of Combined Chemotherapy With Arsenic Trioxide for Stage 4/M Neuroblastoma in Children: A Multicenter Nonrandomized Controlled Trial
   Chunmou Li et al, 2021, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
9. Hedgehog signaling in tissue homeostasis, cancers, and targeted therapies
   Junjun Jing et al, 2023, Signal Transduction and Targeted Therapy CrossRef
10. Current Status of Hedgehog Signaling Inhibitors
    Xiaotang Wang et al, 2024, Current Topics in Medicinal Chemistry CrossRef
11. Arsenic trioxide in pediatric cancer – a case series and review of literature
    Michael Abele et al, 2021, Pediatric Hematology and Oncology CrossRef
12. Arsenic Trioxide inhibits Activation of Hedgehog Pathway in Human Neuroblastoma Cell Line SK-N-BE(2) Independent of Itraconazole
    Xiaoshan Liu et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
13. Chondrosarcoma: A Rare Misfortune in Aging Human Cartilage? The Role of Stem and Progenitor Cells in Proliferation, Malignant Degeneration and Therapeutic Resistance
    Karen Boehme et al, 2018, International Journal of Molecular Sciences CrossRef
14. Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy
    Claudia Paret et al, 2017, Oncotarget CrossRef
15. Targeted Therapy–based Combination Treatment in Rhabdomyosarcoma
    Anke E.M. van Erp et al, 2018, Molecular Cancer Therapeutics CrossRef
16. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β‐catenin pathway
    Jiancang Ma et al, 2019, Journal of Cellular Physiology CrossRef
17. Combined application of arsenic trioxide and lithium chloride augments viability reduction and apoptosis induction in human rhabdomyosarcoma cell lines
    Sabine B. Schleicher et al, 2017, PLOS ONE CrossRef
18. Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies
    Maximilian M. L. Knott et al, 2019, Cancer and Metastasis Reviews CrossRef
19. Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application
    Natalia Banaszek et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
20. Understanding Nexus Between Hydrogeochemical Cycling and Medical Geology of Arsenic
    Muhammad Mahroz Hussain et al, 2023, Medical Geology CrossRef
21. The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer
    Yanfei Jia et al, 2019, Oncogene CrossRef